<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577430</url>
  </required_header>
  <id_info>
    <org_study_id>20200915</org_study_id>
    <nct_id>NCT04577430</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period</brief_title>
  <official_title>Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yangzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yangzhou University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perioperative stress may increase the incidence of adverse events in the cardiovascular&#xD;
      system and lead to poor prognosis. Dexmedetomidine is a highly selective α2 adrenergic&#xD;
      receptor agonist, which can inhibit stress response and reduce hemodynamic fluctuations. In&#xD;
      different usage plans, dexmedetomidine can have different effects on hemodynamics, myocardial&#xD;
      electrical activity, cardiac function. The main purpose was to observe its effects on&#xD;
      myocardial electrophysiology and cardiac function during perioperative period. The secondary&#xD;
      purpose was to explore the optimal dose of dexmedetomidine that has the least adverse effects&#xD;
      on perioperative electrocardia action and cardiac function&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 8, 2019</start_date>
  <completion_date type="Actual">March 16, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The length of PR,QRS,QTc,QT and Tp-e intervals and the level of iCEB</measure>
    <time_frame>during surgery to 1 month after the surgery</time_frame>
    <description>All the outcomes above should be measured at the time preparing to pump a loading dose,the time after the loading dose finished,at the end of surgery,1h after the surgery finished,24 h after the surgery finished,48 h after the surgery finished,72 h after the surgery finished,1 month after the surgery finished</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The level of Na+,iCa2+</measure>
    <time_frame>perioperative</time_frame>
    <description>All the outcomes above should be measured at the time preparing to pump a loading dose,the time after the loading dose finished,1h after the beginning of the surgery,the end of surgery,1h after the surgery finished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of cardiac circulation efficiency</measure>
    <time_frame>Perioperative</time_frame>
    <description>All the outcomes above should be measured at the time preparing to pump a loading dose,the time after the loading dose finished,1h after the beginning of the surgery,the end of surgery,1h after the surgery finished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of maximum pressure gradient</measure>
    <time_frame>Perioperative</time_frame>
    <description>the time preparing to pump a loading dose,the time after the loading dose finished,the beginning of surgery, 30min after the beginning of surgery,1h after the beginning of the surgery,the end of surgery,1h after the surgery finished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of heart rate</measure>
    <time_frame>Perioperative</time_frame>
    <description>the time preparing to pump a loading dose,the time after the loading dose finished,the beginning of surgery, 30min after the beginning of surgery,1h after the beginning of the surgery,the end of surgery,1h after the surgery finished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of mean arterial blood pressure</measure>
    <time_frame>Perioperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of systemic vascular resistance</measure>
    <time_frame>Perioperative</time_frame>
    <description>the time preparing to pump a loading dose,the time after the loading dose finished,the beginning of surgery, 30min after the beginning of surgery,1h after the beginning of the surgery,the end of surgery,1h after the surgery finished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time of eyes opening from surgery ending,the whole surgery,anesthesia</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The dosage of propofol and remifentanil</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fluid intake from entering the operating room to exiting the PACU</measure>
    <time_frame>Perioperative</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Dexmedetomidine</condition>
  <condition>General Anesthesia</condition>
  <condition>Cardiac Electrophysiology</condition>
  <condition>Cardiac Function</condition>
  <arm_group>
    <arm_group_label>Loading dose with 0.5 μg/kg, maintenance dose with 0.5 μg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 min before induction of anesthesia,the loading dose of dexmedetomidine is 0.5 μg/kg, and completed in 10 minutes. The maintenance dose is 0.5 μg/kg per hour during the operation until 0.5 h before the operation finished.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loading dose with 1 μg/kg, maintenance dose with 0.5 μg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 min before induction of anesthesia,the loading dose of dexmedetomidine is 1 μg/kg, and completed in 10 minutes. The maintenance dose is 0.5 μg/kg per hour during the operation until 0.5 h before the surgery finished.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loading dose with 1 μg/kg, maintenance dose with 1 μg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 min before induction of anesthesia,the loading dose of dexmedetomidine is 1 μg/kg, and completed in 10 minutes. The maintenance dose is 1 μg/kg per hour during the operation until 0.5 h before the surgery finished.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>The loading dose with 0.5 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts</description>
    <arm_group_label>Loading dose with 0.5 μg/kg, maintenance dose with 0.5 μg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>The loading dose with 1 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts</description>
    <arm_group_label>Loading dose with 1 μg/kg, maintenance dose with 0.5 μg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>The loading dose with 1 μg/kg, maintenance dose with 1 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts</description>
    <arm_group_label>Loading dose with 1 μg/kg, maintenance dose with 1 μg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Normal saline is used to observe the effect on the electrophysiology of the patients' hearts</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages ranged from 18 to 65&#xD;
&#xD;
          -  ASA I~II&#xD;
&#xD;
          -  patients undergoing elective general anesthesia&#xD;
&#xD;
          -  the surgery time for 1~3 h&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative ECG abnormalities, including QTc ≥440 ms (male), 460ms (female)&#xD;
&#xD;
          -  abnormal cardiac conduction, prolonged QT syndrome&#xD;
&#xD;
          -  heart disease history, such as pacemaker implantation, unstable angina, congestive&#xD;
             heart failure, Heart valve disease&#xD;
&#xD;
          -  antiarrhythmic drugs (β-receptor blockers, calcium channel blockers, tricyclic&#xD;
             antidepressants, etc.) that can prolong the QT interval taken within one week before&#xD;
             surgery&#xD;
&#xD;
          -  coronary heart disease, non-sinus Heart rhythm, bradycardia, tachycardia, other&#xD;
             arrhythmia, etc&#xD;
&#xD;
          -  intraoperative HR≤45 beats/min and need drugs to increase heart rate&#xD;
&#xD;
          -  previous allergy to dexmedetomidine&#xD;
&#xD;
          -  preoperative electrolyte abnormalities&#xD;
&#xD;
          -  emergency surgery, neurological or mental disorders , Liver and kidney dysfunction&#xD;
&#xD;
          -  patients who use analgesic pumps after surgery&#xD;
&#xD;
          -  refusal of patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>the Affiliated Hospital of Yangzhou University, Yangzhou University</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 19, 2020</study_first_submitted>
  <study_first_submitted_qc>October 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yangzhou University</investigator_affiliation>
    <investigator_full_name>Zhuan Zhang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

